All Stories

  1. Patient experiences of benzodiazepine tapering: a qualitative study of treatment in addiction care
  2. Prescription psychostimulants or atomoxetine and the risk of stimulant-related hospital admissions in adults with and without stimulant use disorder: a Swedish population-based within-individual observational study
  3. Prescription psychostimulants, atomoxetine and the risk of psychosis in adults with history of psychosis: a population-based cohort study
  4. Risk of substance use disorders in the adult children of parents with severe alcohol use disorder: a nationwide cohort study
  5. Improved opioid prescribing in primary care: protocol for a cluster randomised pragmatic trial
  6. Substances that underlie a diagnosis of multiple drug use disorder: a 2021-2024 Swedish cohort study
  7. A national cohort study of long-term opioid prescription and sociodemographic and health care-related risk factors
  8. Experiences of long-term benzodiazepine use and addiction amid changes in guidelines for the prescription of narcotic drugs: a qualitative study
  9. Motivation to treatment-seeking among individuals with addiction to benzodiazepines: a qualitative study
  10. Pharmacological Treatments in Alcohol Use Disorder and Risk of Alcohol‐Related Hospitalizations: A Register Study
  11. Antidepressants, relapse-prevention medications and both combined to reduce alcohol-related hospitalizations in individuals with severe alcohol use disorder
  12. A prospective cohort of treatment-seeking patients with problematic use of prescription narcotic drugs: study protocol and baseline characteristics
  13. At the tipping point: Patient experiences of addiction to benzodiazepines and motivation to seek treatment
  14. Excess mortality among people in homelessness with substance use disorders: a Swedish cohort study
  15. Risk of severe mood and anxiety disorders in the adult children of parents with alcohol use disorder: a nationwide cohort study
  16. Treatment of trauma-related conditions for people in homelessness: a scoping review
  17. Characteristics of Patients with Subjective Sleep Problems after Cognitive Behavioral Therapy for Insomnia: Secondary Analyses of a Randomized Controlled Trial
  18. Intolerance-of-uncertainty therapy versus metacognitive therapy for generalized anxiety disorder in primary health care: A randomized controlled pilot trial
  19. Dancing with the patient: a qualitative study of general practitioners’ experiences of managing patients with multimorbidity and common mental health problems
  20. Clinical effectiveness of care managers in collaborative primary health care for patients with depression: 12- and 24-month follow-up of a pragmatic cluster randomized controlled trial
  21. Mortality in adult children of parents with alcohol use disorder: a nationwide register study
  22. Outcomes of psychiatric interviews and self-rated symptom scales in people on sick leave for common mental disorders: an observational study
  23. Cost-effectiveness of a care manager collaborative care programme for patients with depression in primary care: 12-month economic evaluation of a pragmatic randomised controlled trial
  24. P.303 Treatment outcomes in patients with prescription narcotic use disorder (TAPE)
  25. The overall and sex- and age-group specific incidence rates of cancer in people with schizophrenia: a population-based cohort study
  26. Structured psychiatric diagnoses and self-rated symptoms in primary care patients on sick leave for common mental disorders: a clinical study
  27. P2547Statin and glucose-lowering treatment in individuals with and without schizophrenia
  28. Process evaluation of a cluster randomised intervention in Swedish primary care: using care managers in collaborative care to improve care quality for patients with depression
  29. Care managers can be useful for patients with depression but their role must be clear: a qualitative study of GPs’ experiences
  30. Outcome of a psychosocial health promotion intervention aimed at improving physical health and reducing alcohol use in patients with schizophrenia and psychotic disorders (MINT)
  31. Lithium treatment and cancer incidence in bipolar disorder – a large nationwide Swedish register study
  32. Cost-effectiveness of a care manager collaborative care programme for patients with depression in primary care: economic evaluation of a pragmatic randomised controlled study
  33. Creating a safety net for patients with depression in primary care; a qualitative study of care managers’ experiences
  34. Impact of group treatment for insomnia on daytime symptomatology: Analyses from a randomized controlled trial in primary care
  35. Patients’ experiences of motivation, change, and challenges in group treatment for insomnia in primary care: a focus group study
  36. Effects on work ability, job strain and quality of life of monitoring depression using a self-assessment instrument in recurrent general practitioner consultations: A randomized controlled study
  37. Mortality trends in external causes of death in people with mental health disorders in Sweden, 1987–2010
  38. Clinical effectiveness of care managers in collaborative care for patients with depression in Swedish primary health care: a pragmatic cluster randomized controlled trial
  39. Group treatment for insomnia and impact on daytime symptomatology associated with insomnia: analyses from a randomized controlled trial in primary care
  40. Improving insomnia in primary care patients: A randomized controlled trial of nurse-led group treatment
  41. Increased cardiovascular mortality in people with schizophrenia: a 24-year national register study
  42. Use of a self-rating scale to monitor depression severity in recurrent GP consultations in primary care – does it really make a difference? A randomised controlled study
  43. Patients’ perspectives on the use of the Montgomery-Asberg depression rating scale self-assessment version in primary care
  44. Factors associated with self-reported need for treatment of sleeping difficulties: a survey of the general Swedish population
  45. Lithium treatment and cancer incidence in bipolar disorder
  46. Mortality trends in cardiovascular causes in schizophrenia, bipolar and unipolar mood disorder in Sweden 1987–2010
  47. Diabetes and glucose disturbances in patients with psychosis in Sweden
  48. Mortality trends among people with schizophrenia, bipolar disorder and depression, Sweden 1987–2010
  49. Comparison Between the Montgomery-Asberg Depression Rating Scale–Self and the Beck Depression Inventory II in Primary Care
  50. Association between history of psychosis and cardiovascular disease in bipolar disorder
  51. District nurses’ preventive home visits to 75-year-olds: An opportunity to identify factors related to unsafe medication management
  52. Mortality and life expectancy of people with alcohol use disorder in Denmark, Finland and Sweden
  53. Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries
  54. Excess Mortality, Causes of Death and Life Expectancy in 270,770 Patients with Recent Onset of Mental Disorders in Denmark, Finland and Sweden
  55. Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden
  56. Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders
  57. Successful deinstitutionalization of mental health care: increased life expectancy among people with mental disorders in Finland
  58. Migration and self-rated health: a comparison between Finns living in Sweden and Finns living in Finland
  59. Country of Birth and Suicide: A Follow-up Study of a National Cohort in Sweden
  60. Country of birth and hospital admission rates for mental disorders: a cohort study of 4.5 million men and women in Sweden
  61. The Influences of Place of Birth and Socioeconomic Factors on Attempted Suicide in a Defined Population of 4.5 Million People